{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T23:37:23Z","timestamp":1776555443030,"version":"3.51.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,18]]},"DOI":"10.7759\/cureus.107306","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T22:37:26Z","timestamp":1776551846000},"source":"Crossref","is-referenced-by-count":0,"title":["Preoperative MR Perfusion and Intraoperative MR Imaging in Predicting Surgical Resectability and Quality of Life Outcomes in High-Grade Glioma Patients: A Prospective Cohort Analysis and Case Study"],"prefix":"10.7759","author":[{"given":"Omowumi","family":"Oladipo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clayton","family":"Rawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyril L","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Salzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter R","family":"Underhill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Karsy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom QT","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016. Neuro Oncol. 2019, 21:v1-v100. 10.1093\/neuonc\/noz150","journal-title":"Neuro Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1742333","article-title":"Utility of administrative databases and big data on understanding glioma treatment\u2014a systematic review","volume":"11","author":"Owens MR","year":"2022","unstructured":"Owens MR, Nguyen S, Karsy M. Utility of administrative databases and big data on understanding glioma treatment\u2014a systematic review. Indian J Neurosurg. 2022, 11:104-17. 10.1055\/s-0042-1742333","journal-title":"Indian J Neurosurg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3171\/2018.12.JNS183109","article-title":"Evaluation of cost and survival in intracranial gliomas using the Value Driven Outcomes database: a retrospective cohort analysis","volume":"132","author":"Wilde H","year":"2020","unstructured":"Wilde H, Azab MA, Abunimer AM, et al.. Evaluation of cost and survival in intracranial gliomas using the Value Driven Outcomes database: a retrospective cohort analysis. J Neurosurg. 2020, 132:1006-16. 10.3171\/2018.12.JNS183109","journal-title":"J Neurosurg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2001.95.2.0190","article-title":"A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival","volume":"95","author":"Lacroix M","year":"2001","unstructured":"Lacroix M, Abi-Said D, Fourney DR, et al.. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001, 95:190-8. 10.3171\/jns.2001.95.2.0190","journal-title":"J Neurosurg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdac070","article-title":"Dynamic susceptibility contrast MRI may contribute in prediction of stereotactic radiosurgery outcome in brain metastases","volume":"4","author":"Starck L","year":"2022","unstructured":"Starck L, Skeie BS, Moen G, Gr\u00fcner R. Dynamic susceptibility contrast MRI may contribute in prediction of stereotactic radiosurgery outcome in brain metastases. Neurooncol Adv. 2022, 4:7. 10.1093\/noajnl\/vdac070","journal-title":"Neurooncol Adv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2014.01.016","article-title":"DCE and DSC MR perfusion imaging in the differentiation of recurrent tumour from treatment-related changes in patients with glioma","volume":"69","author":"Shin KE","year":"2014","unstructured":"Shin KE, Ahn KJ, Choi HS, Jung SL, Kim BS, Jeon SS, Hong YG. DCE and DSC MR perfusion imaging in the differentiation of recurrent tumour from treatment-related changes in patients with glioma. Clin Radiol. 2014, 69:e264-72. 10.1016\/j.crad.2014.01.016","journal-title":"Clin Radiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2016.03.020","article-title":"Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis","volume":"85","author":"Santarosa C","year":"2016","unstructured":"Santarosa C, Castellano A, Conte GM, et al.. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis. Eur J Radiol. 2016, 85:1147-56. 10.1016\/j.ejrad.2016.03.020","journal-title":"Eur J Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now148","article-title":"MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis","volume":"19","author":"Patel P","year":"2017","unstructured":"Patel P, Baradaran H, Delgado D, Askin G, Christos P, John Tsiouris A, Gupta A. MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis. Neuro Oncol. 2017, 19:118-27. 10.1093\/neuonc\/now148","journal-title":"Neuro Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.22861","article-title":"On the scope and interpretation of the Tofts models for DCE-MRI","volume":"66","author":"Sourbron SP","year":"2011","unstructured":"Sourbron SP, Buckley DL. On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med. 2011, 66:735-45. 10.1002\/mrm.22861","journal-title":"Magn Reson Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-006-9135-z","article-title":"Validation of the M.D. Anderson Symptom Inventory brain tumor module (MDASI-BT)","volume":"80","author":"Armstrong TS","year":"2006","unstructured":"Armstrong TS, Mendoza T, Gning I, et al.. Validation of the M.D. Anderson Symptom Inventory brain tumor module (MDASI-BT). J Neurooncol. 2006, 80:27-35. 10.1007\/s11060-006-9135-z","journal-title":"J Neurooncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1586\/erp.11.67","article-title":"FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: a literature review","volume":"11","author":"Lien K","year":"2011","unstructured":"Lien K, Zeng L, Nguyen J, et al.. FACT-Br for assessment of quality of life in patients receiving treatment for brain metastases: a literature review. Expert Rev Pharmacoecon Outcomes Res. 2011, 11:701-8. 10.1586\/erp.11.67","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020285","article-title":"Pseudoprogression in glioblastoma: role of metabolic and functional MRI-systematic review","volume":"10","author":"Sidibe I","year":"2022","unstructured":"Sidibe I, Tensaouti F, Roques M, Cohen-Jonathan-Moyal E, Laprie A. Pseudoprogression in glioblastoma: role of metabolic and functional MRI-systematic review. Biomedicines. 2022, 10:5. 10.3390\/biomedicines10020285","journal-title":"Biomedicines"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5114\/fn.2023.134180","article-title":"The use of MR perfusion parameters in differentiation between glioblastoma recurrence and radiation necrosis","volume":"61","author":"Bobek-Billewicz B","year":"2023","unstructured":"Bobek-Billewicz B, Heinze S, Awramienko-Wloczek A, Majchrzak K, Nowicka E, Hebda A. The use of MR perfusion parameters in differentiation between glioblastoma recurrence and radiation necrosis. Folia Neuropathol. 2023, 61:371-8. 10.5114\/fn.2023.134180","journal-title":"Folia Neuropathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2174\/1573405618666220324112457","article-title":"Dynamic contrast-enhanced MR perfusion in differentiation of benign and malignant brain lesions","volume":"18","author":"Cetinkaya E","year":"2022","unstructured":"Cetinkaya E, Aralasmak A, Atasoy B, et al.. Dynamic contrast-enhanced MR perfusion in differentiation of benign and malignant brain lesions. Curr Med Imaging. 2022, 18:1099-105. 10.2174\/1573405618666220324112457","journal-title":"Curr Med Imaging"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2472070898","article-title":"Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging","volume":"247","author":"Law M","year":"2008","unstructured":"Law M, Young RJ, Babb JS, et al.. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology. 2008, 247:490-8. 10.1148\/radiol.2472070898","journal-title":"Radiology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0000000000000756","article-title":"Health-related quality of life and cancer-related symptoms during interdisciplinary outpatient rehabilitation for malignant brain tumor","volume":"96","author":"McCarty S","year":"2017","unstructured":"McCarty S, Eickmeyer SM, Kocherginsky M, Keeshin S, Shahpar S, Semik P, Wong AW. Health-related quality of life and cancer-related symptoms during interdisciplinary outpatient rehabilitation for malignant brain tumor. Am J Phys Med Rehabil. 2017, 96:852-60. 10.1097\/PHM.0000000000000756","journal-title":"Am J Phys Med Rehabil"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npab013","article-title":"Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative","volume":"8","author":"Dirven L","year":"2021","unstructured":"Dirven L, Vos ME, Walbert T, et al.. Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative. Neurooncol Pract. 2021, 8:417-25. 10.1093\/nop\/npab013","journal-title":"Neurooncol Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npaa084","article-title":"Spiritual well-being and its association with health-related quality of life in primary brain tumor patients","volume":"8","author":"Randazzo DM","year":"2021","unstructured":"Randazzo DM, McSherry F, Herndon JE 2nd, et al.. Spiritual well-being and its association with health-related quality of life in primary brain tumor patients. Neurooncol Pract. 2021, 8:299-309. 10.1093\/nop\/npaa084","journal-title":"Neurooncol Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac200.023","article-title":"Health-related quality of life in patients with high-grade glioma: a systematic review","volume":"24","author":"Sanpher E","year":"2022","unstructured":"Sanpher E, Mitchell L, Keshwara S, Islim A, Jenkinson M, Millward C. Health-related quality of life in patients with high-grade glioma: a systematic review. Neuro Oncol. 2022, 24:iv5-6. 10.1093\/neuonc\/noac200.023","journal-title":"Neuro Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/407687-preoperative-mr-perfusion-and-intraoperative-mr-imaging-in-predicting-surgical-resectability-and-quality-of-life-outcomes-in-high-grade-glioma-patients-a-prospective-cohort-analysis-and-case-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T22:37:27Z","timestamp":1776551847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/407687-preoperative-mr-perfusion-and-intraoperative-mr-imaging-in-predicting-surgical-resectability-and-quality-of-life-outcomes-in-high-grade-glioma-patients-a-prospective-cohort-analysis-and-case-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.107306","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,18]]}}}